Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Surrozen, Inc./DESRZN · Entity 6092 | Exec. Vice President, Research | June 15, 2026 | June 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Surrozen, Inc./DE
Report date June 15, 2026 · Filed June 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,882 |
Reported balance
After 2026-06-15 transaction · row 1
1 source rowRow 1 · 2026-06-15 · Grant · Acquired 1,666 · Balance 18,882 F1: This reporting person is voluntarily reporting these shares acquired under the Surrozen, Inc. 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| Common StockSEC Table I · non-derivative | IndirectBy daughter | 351 |
Reported balance
Holding disclosure · report date 2026-06-15 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 351 |
| Common StockSEC Table I · non-derivative | IndirectBy son | 351 |
Reported balance
Holding disclosure · report date 2026-06-15 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 351 |
Filing footnotes · ownership attribution and instrument terms
F1: This reporting person is voluntarily reporting these shares acquired under the Surrozen, Inc. 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2026 Filed Jun 16, 2026 20:51 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | GrantCommon Stock | 1,666 | $8.11 | $13,511.26 |
DisclosureSEC source: 0001193125-26-272780 · ownership.xml · nonDerivative · entry 1 Li Yang · CIK 0001990537 · Exec. Vice President, Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,882 F1 · kind: This reporting person is voluntarily reporting these shares acquired under the Surrozen, Inc. 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 04, 2026 Filed May 5, 2026 20:58 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | SaleCommon Stock | 1,584 | $33.33 | $52,799.16 |
DisclosureSEC source: 0001193125-26-206695 · ownership.xml · nonDerivative · entry 2 Li Yang · CIK 0001990537 · Exec. Vice President, Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,216 F2 · price: The shares were sold to cover withholding taxes upon vesting of RSUs in transactions that were initiated by the Issuer on the reporting person's behalf. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.04 to $33.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:58 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | Exercise / conversionRestricted Stock Unit · Derivative | 4,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-206695 · ownership.xml · derivative · entry 5 Li Yang · CIK 0001990537 · Exec. Vice President, Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,375 Underlying: Common Stock · 4,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit, or RSU, represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: These RSUs vest in two equal installments on May 1, 2026 and May 1, 2027. F3 · derivative.expiration_date: These RSUs vest in two equal installments on May 1, 2026 and May 1, 2027. Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:58 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | Exercise / conversionCommon Stock | 4,375 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-206695 · ownership.xml · nonDerivative · entry 1 Li Yang · CIK 0001990537 · Exec. Vice President, Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit, or RSU, represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 31, 2026 Filed Apr 1, 2026 21:43 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | GiftCommon Stock | 1,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-138292 · ownership.xml · nonDerivative · entry 1 Li Yang · CIK 0001990537 · Exec. Vice President, Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,425 F1 · kind: Represents a charitable donation by the Reporting Person. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 23:47 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | GrantRestricted Stock Unit · Derivative | 100,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-057665 · ownership.xml · derivative · entry 2 Li Yang · CIK 0001990537 · Exec. Vice President, Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,950 Underlying: Common Stock · 100,950 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit, or RSU, represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The shares subject to the RSUs vest in four equal annual installments starting on February 1, 2026, subject to the reporting person's continued service through the applicable vesting date. F3 · derivative.expiration_date: The shares subject to the RSUs vest in four equal annual installments starting on February 1, 2026, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 23:47 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | GrantEmployee Stock Option (right to buy) · Derivative | 100,950 | $0.00 Strike: $24.53 | $0.00 |
DisclosureSEC source: 0001193125-26-057665 · ownership.xml · derivative · entry 1 Li Yang · CIK 0001990537 · Exec. Vice President, Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,950 Underlying: Common Stock · 100,950 shares Expires 2036-02-16 F1 · derivative.exercise_date: The shares subject to the option award vest over a four-year period in 48 equal monthly installments measured from February 1, 2026, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 01:25 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | SaleCommon Stock | 1,118 | $19.87 | $22,209.29 |
DisclosureSEC source: 0001193125-26-005094 · ownership.xml · nonDerivative · entry 2 Li Yang · CIK 0001990537 · Exec. Vice President, Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,091 F2 · price: The shares were sold to cover withholding taxes upon vesting of RSUs in transactions that were initiated by the Issuer on the reporting person's behalf. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.84 to $20.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 02, 2026 Filed Jan 7, 2026 01:25 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-005094 · ownership.xml · derivative · entry 5 Li Yang · CIK 0001990537 · Exec. Vice President, Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit, or RSU, represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: These RSUs vested in two equal installments on January 1, 2025 and January 1, 2026. F3 · derivative.expiration_date: These RSUs vested in two equal installments on January 1, 2025 and January 1, 2026. Read SEC document |
| January 02, 2026 Filed Jan 7, 2026 01:25 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | Exercise / conversionCommon Stock | 2,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-005094 · ownership.xml · nonDerivative · entry 1 Li Yang · CIK 0001990537 · Exec. Vice President, Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit, or RSU, represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 00:14 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | GrantCommon Stock | 1,666 | $8.11 | $13,511.26 |
DisclosureSEC source: 0001193125-25-321315 · ownership.xml · nonDerivative · entry 1 Li Yang · CIK 0001990537 · Exec. Vice President, Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,709 F1 · kind: This reporting person is voluntarily reporting these shares acquired under the Surrozen, Inc. 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 22:58 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | GrantCommon Stock | 400 | $8.06 | $3,224.00 |
DisclosureSEC source: 0001593968-25-000787 · primary_01.xml · nonDerivative · entry 1 Li Yang · CIK 0001990537 · Exec. Vice President, Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,043 F1 · kind: This reporting person is voluntarily reporting these shares acquired under the Surrozen, Inc. 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 01, 2025 Filed May 5, 2025 20:26 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | GrantRestricted Stock Unit · Derivative | 8,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-25-000593 · primary_01.xml · derivative · entry 2 Li Yang · CIK 0001990537 · Exec. Vice President, Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,750 Underlying: Common Stock · 8,750 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit, or RSU, represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The shares subject to the RSU award vest over a two-year period as to 50% of such shares on each of the first and second annual anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date. F3 · derivative.expiration_date: The shares subject to the RSU award vest over a two-year period as to 50% of such shares on each of the first and second annual anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| May 01, 2025 Filed May 5, 2025 20:26 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | GrantOption (right to buy) · Derivative | 26,250 | $0.00 Strike: $10.48 | $0.00 |
DisclosureSEC source: 0001593968-25-000593 · primary_01.xml · derivative · entry 1 Li Yang · CIK 0001990537 · Exec. Vice President, Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,250 Underlying: Common Stock · 26,250 shares Expires 2035-05-01 F1 · derivative.exercise_date: The shares subject to the option award vest over a four-year period in 48 equal monthly installments measured from grant date, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| January 17, 2025 Filed Jan 23, 2025 02:26 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | GrantOption (right to buy) · Derivative | 35,000 | $0.00 Strike: $12.08 | $0.00 |
DisclosureSEC source: 0001593968-25-000111 · primary_01.xml · derivative · entry 1 Li Yang · CIK 0001990537 · Exec. Vice President, Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2035-01-17 F1 · derivative.exercise_date: The shares subject to the options vest and become exercisable in a series of 48 equal monthly installments beginning on February 1, 2025, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 02:13 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | SaleCommon Stock | 843 | $17.37 | $14,642.91 |
DisclosureSEC source: 0001593968-25-000043 · primary_01.xml · nonDerivative · entry 2 Li Yang · CIK 0001990537 · Exec. Vice President, Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,345 F3 · price: The shares were sold to cover withholding taxes upon vesting of RSUs in transactions that were initiated by the Issuer on the reporting person's behalf. The price reported reflects the volume-weighted average price for the transactions. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 02:13 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | Exercise / conversionCommon Stock | 2,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001593968-25-000043 · primary_01.xml · nonDerivative · entry 1 Li Yang · CIK 0001990537 · Exec. Vice President, Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit, or RSU, represents a contingent right to receive one share of the Issuer's common stock. This transaction represents the settlement of vested RSUs in shares of Issuer's common stock. F2 · balance_after: Includes 400 shares purchased at a price of $5.67 per share pursuant to the Issuer's 2021 Employee Stock Purchase Plan on December 13, 2024, and 702 shares held through immediate family members of the reporting person. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 23:44 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | GrantCommon Stock | 400 | $5.67 | $2,268.00 |
DisclosureSEC source: 0001593968-24-000869 · primary_01.xml · nonDerivative · entry 1 Li Yang · CIK 0001990537 · Exec. Vice President, Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,888 F1 · kind: This reporting person is voluntarily reporting these shares acquired under the Surrozen, Inc. 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 01, 2024 Filed May 3, 2024 00:12 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | GrantOption (right to buy) · Derivative | 20,000 | $0.00 Strike: $9.89 | $0.00 |
DisclosureSEC source: 0001593968-24-000680 · primary_01.xml · derivative · entry 1 Li Yang · CIK 0001990537 · Exec. Vice President, Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-05-01 F1 · derivative.exercise_date: The shares subject to the options vest and become exercisable in a series of 48 equal monthly installments beginning on June 1, 2024, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| April 24, 2024 Filed Apr 26, 2024 20:39 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | GrantRestricted Stock Unit · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-24-000622 · primary_01.xml · derivative · entry 2 Li Yang · CIK 0001990537 · Exec. Vice President, Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit, or RSU, represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSU award vests in two equal installments on January 1, 2025 and January 1, 2026. F3 · derivative.expiration_date: The RSU award vests in two equal installments on January 1, 2025 and January 1, 2026. Read SEC document |
| April 24, 2024 Filed Apr 26, 2024 20:39 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | GrantOption (right to buy) · Derivative | 10,000 | $0.00 Strike: $8.97 | $0.00 |
DisclosureSEC source: 0001593968-24-000622 · primary_01.xml · derivative · entry 1 Li Yang · CIK 0001990537 · Exec. Vice President, Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-04-24 F1 · derivative.exercise_date: The shares subject to the options vest and become exercisable in a series of 48 equal monthly installments beginning on February 1, 2024, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 02:26 UTC | Surrozen, Inc./DE SRZN · Entity 6092 | GrantCommon Stock | 2,085 | $5.67 | $11,821.95 |
DisclosureSEC source: 0001593968-23-001518 · primary_01.xml · nonDerivative · entry 1 Li Yang · CIK 0001990537 · Exec. Vice President, Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,085 F1 · kind: This reporting person is voluntarily reporting these shares acquired under the Surrozen, Inc. 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). F2 · shares: On December 13, 2023, Surrozen, Inc. effected a one-for-fifteen reverse stock split of its outstanding common stock (the "Reverse Stock Split"). All amounts of securities listed herein have been adjusted to reflect the effect of the Reverse Stock Split. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.